![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/28/2936830/0/en/Compass-Pathways-to-participate-in-three-investor-conferences-in-September.html
https://www.globenewswire.com/news-release/2024/08/06/2924997/0/en/COMPASS-Pathways-to-participate-in-Canaccord-Genuity-44th-Annual-Growth-Conference.html
https://www.globenewswire.com/news-release/2024/08/01/2922581/0/en/Compass-Pathways-announces-second-quarter-2024-financial-results-and-business-highlights.html
https://www.globenewswire.com/news-release/2024/07/24/2917887/0/en/Compass-Pathways-to-announce-second-quarter-financial-results-on-August-1-2024.html
https://www.globenewswire.com/news-release/2024/06/26/2904355/0/en/Compass-Pathways-appoints-Lori-Englebert-as-Chief-Commercial-Officer.html
https://www.globenewswire.com/news-release/2024/06/24/2903343/0/en/Compass-Pathways-to-participate-in-upcoming-H-C-Wainwright-5th-Annual-Neuro-Perspectives-Virtual-Conference.html
https://www.reuters.com/business/healthcare-pharmaceuticals/fda-panel-review-psychedelic-drug-mdma-first-time-2024-06-04/
https://www.fiercebiotech.com/biotech/compass-tracks-ptsd-improvements-psilocybin-therapy-sails-midphase-data-drop
https://www.globenewswire.com/news-release/2024/05/08/2877623/0/en/Compass-Pathways-Announces-First-Quarter-2024-Financial-Results-and-Business-Highlights.html
https://www.globenewswire.com/news-release/2024/05/08/2877609/0/en/Compass-Pathways-announces-durable-improvement-in-symptoms-through-12-weeks-in-open-label-phase-2-study-of-COMP360-psilocybin-in-post-traumatic-stress-disorder.html